Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP862770.RAKhdI9IO88gtDwJqTh4DcGzZbUWYP9rNKk2uCP7Teo4Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP862770.RAKhdI9IO88gtDwJqTh4DcGzZbUWYP9rNKk2uCP7Teo4Y130_assertion type Assertion NP862770.RAKhdI9IO88gtDwJqTh4DcGzZbUWYP9rNKk2uCP7Teo4Y130_head.
- NP862770.RAKhdI9IO88gtDwJqTh4DcGzZbUWYP9rNKk2uCP7Teo4Y130_assertion wasGeneratedBy ECO_0000203 NP862770.RAKhdI9IO88gtDwJqTh4DcGzZbUWYP9rNKk2uCP7Teo4Y130_provenance.
- NP862770.RAKhdI9IO88gtDwJqTh4DcGzZbUWYP9rNKk2uCP7Teo4Y130_assertion wasDerivedFrom befree-20140225 NP862770.RAKhdI9IO88gtDwJqTh4DcGzZbUWYP9rNKk2uCP7Teo4Y130_provenance.
- NP862770.RAKhdI9IO88gtDwJqTh4DcGzZbUWYP9rNKk2uCP7Teo4Y130_assertion SIO_000772 10436809 NP862770.RAKhdI9IO88gtDwJqTh4DcGzZbUWYP9rNKk2uCP7Teo4Y130_provenance.
- NP862770.RAKhdI9IO88gtDwJqTh4DcGzZbUWYP9rNKk2uCP7Teo4Y130_assertion evidence source_evidence_literature NP862770.RAKhdI9IO88gtDwJqTh4DcGzZbUWYP9rNKk2uCP7Teo4Y130_provenance.
- NP862770.RAKhdI9IO88gtDwJqTh4DcGzZbUWYP9rNKk2uCP7Teo4Y130_assertion description "[For biliopancreatic malignancy, following CEA as more historical and basic TM of gastrointestinal diseases, the mainstay marker is CA 19-9 as monosialo-ganglioside/glycolipid and sialyl derivative of lacto-N-fucopentaose II (sialyl-Lewis(a), hapten of human Lewis(a) bloodgroup determinant).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862770.RAKhdI9IO88gtDwJqTh4DcGzZbUWYP9rNKk2uCP7Teo4Y130_provenance.